Axogen to Acquire BioCircuit Technologies for $200 Million

06:38 AM EDT, 09/10/2026 (MT Newswires) -- Axogen (AXGN) has agreed to acquire privately held medical device company BioCircuit Technologies for $200 million in cash, the company said Thursday. The acquisition is expected to be funded with net proceeds from a public offering of the company's common stock, which was reported Thursday, the company said. Axogen expects the acquisition to be additive to 2027 revenue, accretive to margins and to maintain positive free cash flow, with full-year 2027 guidance to be provided in Q1, the company said. The transaction is expected to close in Q4.